Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer

被引:0
|
作者
Rui Kang
Yangchun Xie
Qiuhong Zhang
Wen Hou
Qingping Jiang
Shan Zhu
Jinbao Liu
Dexing Zeng
Haichao Wang
David L Bartlett
Timothy R Billiar
Herbert J Zeh
Michael T Lotze
Daolin Tang
机构
[1] The Third Affiliated Hospital,Department of Medicine
[2] Center for DAMP Biology,Department of Surgery
[3] Key Laboratory for Major Obstetric Diseases of Guangdong Province,undefined
[4] Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes,undefined
[5] Protein Modification and Degradation Laboratory,undefined
[6] Guangzhou Medical University,undefined
[7] University of Pittsburgh,undefined
[8] Laboratory of Emergency Medicine,undefined
[9] The Feinstein Institute for Medical Research,undefined
[10] Hillman Cancer Center,undefined
[11] University of Pittsburgh,undefined
来源
Cell Research | 2017年 / 27卷
关键词
HMGB1; RAGE; histone; K-Ras; pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular link between these two events in pancreatic tumorigenesis has not yet been fully established. Here, we show that intracellular high mobility group box 1 (HMGB1) remarkably suppresses oncogenic K-Ras-driven pancreatic tumorigenesis by inhibiting chromosome instability-mediated pro-inflammatory nucleosome release. Conditional genetic ablation of either single or both alleles of HMGB1 in the pancreas renders mice extremely sensitive to oncogenic K-Ras-driven initiation of precursor lesions at birth, including pancreatic intraepithelial neoplasms, intraductal papillary mucinous neoplasms, and mucinous cystic neoplasms. Loss of HMGB1 in the pancreas is associated with oxidative DNA damage and chromosomal instability characterized by chromosome rearrangements and telomere abnormalities. These lead to inflammatory nucleosome release and propagate K-Ras-driven pancreatic tumorigenesis. Extracellular nucleosomes promote interleukin 6 (IL-6) secretion by infiltrating macrophages/neutrophils and enhance oncogenic K-Ras signaling activation in pancreatic lesions. Neutralizing antibodies to IL-6 or histone H3 or knockout of the receptor for advanced glycation end products all limit K-Ras signaling activation, prevent cancer development and metastasis/invasion, and prolong animal survival in Pdx1-Cre;K-RasG12D/+;Hmgb1−/− mice. Pharmacological inhibition of HMGB1 loss by glycyrrhizin limits oncogenic K-Ras-driven tumorigenesis in mice under inflammatory conditions. Diminished nuclear and total cellular expression of HMGB1 in PDAC patients correlates with poor overall survival, supporting intracellular HMGB1 as a novel tumor suppressor with prognostic and therapeutic relevance in PDAC.
引用
收藏
页码:916 / 932
页数:16
相关论文
共 50 条
  • [21] HMGB1 and RAGE in Inflammation and Cancer
    Sims, Gary P.
    Rowe, Daniel C.
    Rietdijk, Svend T.
    Herbst, Ronald
    Coyle, Anthony J.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 28, 2010, 28 : 367 - 388
  • [22] HMGB1 IN THE PATHOGENESIS OF COLORECTAL CANCER
    Hapca, Sandra
    Brice, Daniel P.
    Berry, Susan
    Murray, Graeme I.
    McLean, Mairi H.
    GUT, 2018, 67 : A192 - A192
  • [23] The role of HMGB1 in digestive cancer
    Chen, Xiangqi
    Liu, Qian
    Wu, Enqing
    Ma, Zhiyuan
    Tuo, Biguang
    Terai, Shuji
    Li, Taolang
    Liu, Xuemei
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [24] The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
    R Kang
    D Tang
    N E Schapiro
    T Loux
    K M Livesey
    T R Billiar
    H Wang
    B Van Houten
    M T Lotze
    H J Zeh
    Oncogene, 2014, 33 : 567 - 577
  • [25] The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
    Kang, R.
    Tang, D.
    Schapiro, N. E.
    Loux, T.
    Livesey, K. M.
    Billiar, T. R.
    Wang, H.
    Van Houten, B.
    Lotze, M. T.
    Zeh, H. J.
    ONCOGENE, 2014, 33 (05) : 567 - 577
  • [26] Intracellular HMGB1: defender of client proteins and cell fate
    Chang, Eugene
    ONCOTARGET, 2015, 6 (11) : 8432 - 8433
  • [27] Endothelial HMGB1 (High-Mobility Group Box 1) Regulation of LDL (Low-Density Lipoprotein) Transcytosis: A Novel Mechanism of Intracellular HMGB1 in Atherosclerosis
    Zhang, Xinbo
    Fernandez-Hernando, Carlos
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (01) : 217 - 219
  • [28] HMGB1: a regulator of myeloid-derived suppressor cell potency?
    Parker, Katherine
    Ostrand-Rosenberg, Suzanne
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [29] Inhibition of tumor angiogenesis by HMGB1 A box peptide
    Zhang, Cai-Lian
    Shu, Mao-Guo
    Qi, Hao-Wen
    Li, Li-Wen
    MEDICAL HYPOTHESES, 2008, 70 (02) : 343 - 345
  • [30] Exosomal HMGB1 Promoted Cancer Malignancy
    Wang, Jiaan-Der
    Wang, Ya-Yu
    Lin, Shih-Yi
    Chang, Cheng-Yi
    Li, Jian-Ri
    Huang, Shi-Wei
    Chen, Wen-Ying
    Liao, Su-Lan
    Chen, Chun-Jung
    CANCERS, 2021, 13 (04) : 1 - 16